A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial.

Pérez V Borrás, JP López-Siguero, G Martínez, R Corripio, JM Fernández, JI Labarta, M Ferrer, N Cabrinety, P Prieto, M Ramón-Krauel, J Bosch, R Espino, Garcia M Palla, FJ Rebollo

Research output: Contribution to journalArticleResearchpeer-review

Original languageUndefined/Unknown
JournalAdvances in Therapy
Publication statusPublished - Feb 2015

Cite this